# Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

> **NCT02557958** · EARLY_PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 19 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02557958
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557958, "Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02557958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*